[Detection of development of resistance in the short-term test (author's transl].
By treatment of the mouse leukemia L 1210 with cytosinarabinoside (120 mg/kg per week) a tumour cell line was developed which was resistant to this cytostatic agent. It is possible, using the short-term test, to follow the development of resistance to cytosinarabinoside.
D000818:Animals; D003561:Cytarabine / Q000627:therapeutic use; D004351:Drug Resistance; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice
D003561:Cytarabine
Nachweis einer Resistenzentwicklung bei der Leukämie L 1210 mit dem in vitro-Kurzzeittest.